What does Amelgem do?
AMELGEM specializes in the development and production of high-quality pharmaceutical products. The company focuses on innovative solutions to enhance patient care and improve health outcomes. With a commitment to research and development, AMELGEM aims to address unmet medical needs effectively.
- Sectors
- Consultancy firms Holding companies
- Activities
- Signals
-
ProfitableProfitable € 18K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 4.37MStrong equity provides a buffer against setbacks.
Low riskLow risk 85.8%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 109KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 105KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 8.7%Social debts stay manageable relative to personnel costs.
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
270K
|
€
208K
|
€
200K
|
€
149K
|
|
|
€
105K
|
€
79K
|
€
82K
|
€
75K
|
|
|
€
18K
|
€
6K
|
€
10K
|
€
-4K
|
|
|
€
4.37M
|
€
4.35M
|
€
4.35M
|
€
4.34M
|
|
|
85.76%
|
82.85%
|
87.07%
|
91.92%
|
|
|
€
726K
|
€
901K
|
€
645K
|
€
381K
|
|
|
€
5K
|
€
256K
|
€
5K
|
€
222
|
|
|
3.50
|
3.50
|
3.50
|
3.50
|
Publications 4
All publications- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Wijziging Rechtsvorm - Ontslagen - Benoemingen 25/03/2024
- Ontslagen - Benoemingen 05/03/2021
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Diversen 30/09/2019
- Rubriek Oprichting (Nieuwe Rechtspersoon, Opening Bijkantoor, Enz...) 18/01/2018
Frequently asked questions
Answers to the most common questions about Amelgem, based on official government data and the filed annual accounts.
What is the VAT number of Amelgem?
The VAT number of Amelgem is BE0688.531.041.
How many employees work at Amelgem?
In 2025, Amelgem employed 3.50 full-time equivalents (FTE).
When was Amelgem established?
Amelgem was founded in 16-01-2018.
What is the official address of Amelgem?
The official address of Amelgem is Bosweg 1 Meise 1860.
What is the legal form of Amelgem?
The juridical form of Amelgem is Private limited company (BV/SRL).
What is the annual revenue of Amelgem?
The 2025 accounts of Amelgem do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
What does Amelgem do?
AMELGEM specializes in the development and production of high-quality pharmaceutical products. The company focuses on innovative solutions to enhance patient care and improve health outcomes. With a commitment to research and development, AMELGEM aims to address unmet medical needs effectively.
Is Amelgem a reliable company?
Amelgem is a registered Rechtspersoon with company number 0688.531.041 and can be verified through the official CBE database.
What is the credit limit of Amelgem?
The estimated credit limit of Amelgem is €282,850.
Is Amelgem still active?
Amelgem currently has the status "Normal situation" and is active.